MMP2 and cerebral cavernous malformation: To test this hypothesis, the present study first analyzed the efficacy of CCM in affecting VM formation in malignant GBM U251 cells, and then examined the expression of EphA2, PI3K and MMP-2 by quantitative PCR and western blot assay following CCM treatment.